Clients know what sets us apart. They come to us for our commercially-minded, no-nonsense approach. We take great care in getting to know them, their businesses and their aspirations, and are perfectly positioned to provide creative and original solutions.

 

Thinking ahead of the game. We do a lot of it. In addition to working with the world’s most innovative organisations, we regularly contribute thoughts and insights on the things that matter most to you and your business, from the hypothetical and philosophical to technical and detailed-driven content that brings clarity to the world of European IP. 

 

We work with clients from just about every industry sector. This means that day to day our attorneys are dealing with a hugely diverse and constantly changing range of intellectual property issues – new technologies, evolving consumer behaviours and shifting business practices.

Back profile

Oliver is an associate in our Life Sciences and Chemistry group. He is a European patent attorney, chartered UK patent attorney and is registered to represent clients before the Unified Patent Court (UPC).
 
He specialises in biotechnology, advising a broad spectrum of clients on a diverse range of technologies, including pharmaceuticals, vaccine technology, mRNA therapies, biomarkers, synthetic biology, gene therapy and enzymology. Oliver has considerable experience in mRNA technology, particularly vaccine formulation, and used this to support a large international litigation relating to COVID-19 vaccines.
 
His passion is to work closely with his clients to deliver bespoke patenting strategies resulting in optimum protection. As well as being an expert in patent prosecution, Oliver advises on patent infringement, validity, and EPO opposition matters.
 
His understanding of his clients’ needs has been honed by a secondment in the patent department of a multinational pharmaceutical and biotechnology company, and prior to becoming a patent attorney, working at the biopharmaceutical company UCB, where he specialised in antibody discovery using phage display technology.
 
Previously, Oliver graduated with a MSci (Hons) in Natural Sciences (Biology and Physics) from The University of Nottingham. After developing a keen interested in patents, he then went on to study an MSc in Management of Intellectual Property at Queen Mary University of London and was awarded the Herchel Smith Scholarship in 2016/17.

Qualifications

European Patent Attorney 
Chartered UK Patent Attorney 
Representative before the Unified Patent Court (UPC) (2023)
MSc Management of Intellectual Property (Herchel Smith Scholarship) – Queen Mary University of London (2017)
MSc Natural Sciences (Hons) – The University of Nottingham (2013)

Memberships

BioIndustry Association (BIA)
Chartered Institute of Patent Attorneys (CIPA)
The Institute of Professional Representatives before the European Patent Office (EPI)
International Association for the Protection of Intellectual Property (AIPPI)
IPSoc